APP and Hyperglycemia: Pdx1+/− mice (a chronic hyperglycaemia mouse model) crossed with an APP/PS1 mouse exhibited increased tau phosphorylation, increased synaptic loss in the hippocampus, increased microglial and astrocyte activation, glucose intolerance and Aβ plaque formation (Guo et al., 2016).